Literature DB >> 12196403

Historical intensity of natural selection for resistance to tuberculosis.

Marc Lipsitch1, Alexandra O Sousa.   

Abstract

Infections have long been thought to exert natural selection on humans. Infectious disease resistance is frequently invoked as a mechanism shaping human genetic diversity, but such hypotheses have rarely been quantitatively evaluated with direct measures of disease-related mortality. Enhancement of genetically determined resistance to tuberculosis by natural selection has been proposed as a factor explaining the decline of tuberculosis in Europe and North America in the period 1830-1950 (before the advent of antimicrobial chemotherapy) and the apparently reduced susceptibility of Europeans and their descendants to tuberculosis infection and/or disease. We used Swedish vital statistics from 1891 to 1900 to estimate that individuals who escaped mortality from pulmonary tuberculosis (PTB) during the European tuberculosis epidemic would have enjoyed a fitness advantage of 7-15% per generation compared to individuals who were susceptible to PTB mortality; individuals with 50% protection would have had a selection coefficient of 4-7%/generation. Selection during the peak of the European TB epidemic could have substantially reduced the frequency of already rare alleles conferring increased susceptibility to PTB mortality, but only if the phenotypic effects of these alleles were very large. However, if resistant alleles were rare at the beginning of this period, 300 years would not have been long enough for such selection to increase their frequency to epidemiologically significant levels. Reductions in the frequency of rare susceptibility alleles could have played at most a small part in the decline of the epidemic in the century preceding 1950. Natural selection by PTB deaths during the European TB epidemic alone cannot account for the presently low level of TB disease observed among Europeans and their descendants just prior to the appearance of antibiotic treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12196403      PMCID: PMC1462208     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  23 in total

1.  The historical decline of tuberculosis in Europe and America: its causes and significance.

Authors:  L G Wilson
Journal:  J Hist Med Allied Sci       Date:  1990-07       Impact factor: 2.088

2.  Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.

Authors:  J C Stephens; D E Reich; D B Goldstein; H D Shin; M W Smith; M Carrington; C Winkler; G A Huttley; R Allikmets; L Schriml; B Gerrard; M Malasky; M D Ramos; S Morlot; M Tzetis; C Oddoux; F S di Giovine; G Nasioulas; D Chandler; M Aseev; M Hanson; L Kalaydjieva; D Glavac; P Gasparini; E Kanavakis; M Claustres; M Kambouris; H Ostrer; G Duff; V Baranov; H Sibul; A Metspalu; D Goldman; N Martin; D Duffy; J Schmidtke; X Estivill; S J O'Brien; M Dean
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 3.  Genetics and pulmonary medicine. 3. Genetic susceptibility to tuberculosis in human populations.

Authors:  R Bellamy
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

4.  What maintains the frequencies of human genetic diseases?

Authors:  J I Rotter; J M Diamond
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

5.  Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans.

Authors:  R Bellamy; C Ruwende; T Corrah; K P McAdam; H C Whittle; A V Hill
Journal:  N Engl J Med       Date:  1998-03-05       Impact factor: 91.245

6.  An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon.

Authors:  A O Sousa; J I Salem; F K Lee; M C Verçosa; P Cruaud; B R Bloom; P H Lagrange; H L David
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 7.  Mendelian susceptibility to mycobacterial infection in man.

Authors:  F Altare; E Jouanguy; S Lamhamedi; R Döffinger; A Fischer; J L Casanova
Journal:  Curr Opin Immunol       Date:  1998-08       Impact factor: 7.486

Review 8.  Transmission of tubercle bacilli: The effects of chemotherapy.

Authors:  A Rouillon; S Perdrizet; R Parrot
Journal:  Tubercle       Date:  1976-12

9.  Genetic and evolutionary implications in peptic ulcer disease.

Authors:  G M Petersen; J I Rotter
Journal:  Am J Phys Anthropol       Date:  1983-09       Impact factor: 2.868

10.  The intrinsic transmission dynamics of tuberculosis epidemics.

Authors:  S M Blower; A R McLean; T C Porco; P M Small; P C Hopewell; M A Sanchez; A R Moss
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

View more
  17 in total

1.  Non-clinical factors associated with TB: important for DOTS impact evaluation and disease elimination.

Authors:  Philip C Hill; Christopher C Whalen
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-07-24       Impact factor: 2.184

Review 2.  Old and new selective pressures on Mycobacterium tuberculosis.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Infect Genet Evol       Date:  2011-08-17       Impact factor: 3.342

Review 3.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 4.  Host-pathogen coevolution in human tuberculosis.

Authors:  Sebastien Gagneux
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

5.  Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis.

Authors:  M Cristina Gutierrez; Sylvain Brisse; Roland Brosch; Michel Fabre; Bahia Omaïs; Magali Marmiesse; Philip Supply; Veronique Vincent
Journal:  PLoS Pathog       Date:  2005-08-19       Impact factor: 6.823

6.  Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis.

Authors:  Luis B Barreiro; Olivier Neyrolles; Chantal L Babb; Ludovic Tailleux; Hélène Quach; Ken McElreavey; Paul D van Helden; Eileen G Hoal; Brigitte Gicquel; Lluis Quintana-Murci
Journal:  PLoS Med       Date:  2006-01-03       Impact factor: 11.069

7.  An autosomal dominant major gene confers predisposition to pulmonary tuberculosis in adults.

Authors:  Jamila El Baghdadi; Marianna Orlova; Andrea Alter; Brigitte Ranque; Mohamed Chentoufi; Faouzia Lazrak; Moulay Idriss Archane; Jean-Laurent Casanova; Abdellah Benslimane; Erwin Schurr; Laurent Abel
Journal:  J Exp Med       Date:  2006-06-26       Impact factor: 14.307

Review 8.  Co-evolution of Mycobacterium tuberculosis and Homo sapiens.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

9.  Drosophila melanogaster Selection for Survival of Bacillus cereus Infection: Life History Trait Indirect Responses.

Authors:  Junjie Ma; Andrew K Benson; Stephen D Kachman; Zhen Hu; Lawrence G Harshman
Journal:  Int J Evol Biol       Date:  2012-10-09

10.  Year of birth effects in the historical decline of tuberculosis mortality: a reconsideration.

Authors:  Romola J Davenport
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.